Susquehanna International Group’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$120K Sell
11,570
-890
-7% -$9.25K ﹤0.01% 5824
2025
Q1
$164K Buy
+12,460
New +$164K ﹤0.01% 5628
2024
Q2
Sell
-1,505
Closed -$29.3K 6445
2024
Q1
$29.3K Sell
1,505
-3,863
-72% -$75.3K ﹤0.01% 5252
2023
Q4
$111K Buy
+5,368
New +$111K ﹤0.01% 5303
2023
Q3
Sell
-1,198
Closed -$40.2K 6234
2023
Q2
$40.2K Sell
1,198
-26,838
-96% -$902K ﹤0.01% 5250
2023
Q1
$1.17M Buy
28,036
+27,347
+3,969% +$1.14M ﹤0.01% 2669
2022
Q4
$23.4K Sell
689
-571
-45% -$19.4K ﹤0.01% 5324
2022
Q3
$61K Sell
1,260
-3,294
-72% -$159K ﹤0.01% 5448
2022
Q2
$179K Buy
4,554
+3,305
+265% +$130K ﹤0.01% 4652
2022
Q1
$46K Sell
1,249
-3,642
-74% -$134K ﹤0.01% 5328
2021
Q4
$478K Sell
4,891
-472
-9% -$46.1K ﹤0.01% 3870
2021
Q3
$669K Buy
5,363
+4,020
+299% +$501K ﹤0.01% 3304
2021
Q2
$168K Buy
+1,343
New +$168K ﹤0.01% 4921
2021
Q1
Sell
-547
Closed -$50K 5671
2020
Q4
$50K Buy
547
+152
+38% +$13.9K ﹤0.01% 4618
2020
Q3
$29K Buy
+395
New +$29K ﹤0.01% 4278
2020
Q2
Sell
-9,621
Closed -$696K 4807
2020
Q1
$696K Buy
+9,621
New +$696K ﹤0.01% 2479
2019
Q4
Hold
0
4667
2019
Q3
Hold
0
4924
2019
Q1
Sell
-423
Closed -$34K 4266
2018
Q4
$34K Sell
423
-1,508
-78% -$121K ﹤0.01% 3387
2018
Q3
$901K Buy
+1,931
New +$901K ﹤0.01% 1541
2018
Q2
Sell
-672
Closed -$205K 4516
2018
Q1
$205K Buy
+672
New +$205K ﹤0.01% 2812
2017
Q2
Sell
-447
Closed -$192K 4207
2017
Q1
$192K Buy
+447
New +$192K ﹤0.01% 2840